(Q37716740)

22 August 2017

1 reference

title

Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations (English)

1 reference

22 August 2017

1 reference

1 reference

7

Werner Poewe

1 reference

22 August 2017

8

Cristina Sampaio

1 reference

22 August 2017

9

Olivier Rascol

1 reference

22 August 2017

12

Christopher G Goetz

1 reference

22 August 2017

3

Giovanni Fabbrini

1 reference

22 August 2017

1

Carlo Colosimo

1 reference

22 August 2017

4

Robert A Hauser

1 reference

22 August 2017

11

Anette Schrag

1 reference

PubMed ID

20310033

22 August 2017

Pablo Martinez-Martin

series ordinal

2

object named as

Pablo Martínez-Martín

1 reference

22 August 2017

6

Janis Miyasaki

1 reference

22 August 2017

5

Marcelo Merello

1 reference

22 August 2017

Glenn T Stebbins

10

1 reference

PubMed ID

20310033

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

25

1 reference

22 August 2017

9

1 reference

22 August 2017

1131-1142

1 reference

Levodopa-induced dyskinesias

22 August 2017

1 reference

Analysis of L-dopa induced dyskinesias in 51 patients with Parkinsonism

21 January 2018

1 reference

Drug Insight: new drugs in development for Parkinson's disease

21 January 2018

1 reference

Depression rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

Scales to assess psychosis in Parkinson's disease: Critique and recommendations

21 January 2018

1 reference

Anxiety rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

21 January 2018

1 reference

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

21 January 2018

1 reference

Core assessment program for intracerebral transplantations (CAPIT)

21 January 2018

1 reference

Utility of an objective dyskinesia rating scale for Parkinson's disease: inter- and intrarater reliability assessment.

21 January 2018

1 reference

Evaluation of dyskinesias in a pilot, randomized, placebo-controlled trial of remacemide in advanced Parkinson disease.

21 January 2018

1 reference

Quantifying the impact of dyskinesias in PD: the PDYS-26: a patient-based outcome measure

21 January 2018

1 reference

Reliability and applicability of movement disorder rating scales in the elderly.

21 January 2018

1 reference

Accelerometric assessment of levodopa-induced dyskinesias in Parkinson's disease

21 January 2018

1 reference

Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial

21 January 2018

1 reference

Globus pallidus stimulation improves both motor and nonmotor aspects of quality of life in advanced Parkinson's disease.

21 January 2018

1 reference

The Unified Parkinson's Disease Rating Scale (UPDRS): status and recommendations

21 January 2018

1 reference

Cannabis for dyskinesia in Parkinson disease: a randomized double-blind crossover study

21 January 2018

1 reference

Unified Parkinson's Disease Rating Scale characteristics and structure. The Cooperative Multicentric Group.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.23072

1 reference

22 August 2017

1 reference

PubMed ID

20310033